O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition

Aishwarya Gondane1, Ninu Poulose2,3, Suzanne Walker4

  • 1Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.

Glycobiology
|June 16, 2022
PubMed

Insights

Combining O-GlcNAc transferase (OGT) and cyclin-dependent kinase 9 (CDK9) inhibition is toxic to prostate cancer. Vitamin B5 supplementation mimics this combined effect with CDK9 inhibition, offering a potential therapeutic strategy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Co-targeting O-GlcNAc transferase (OGT) and cyclin-dependent kinase 9 (CDK9) demonstrates toxicity in prostate cancer cells.
  • OGT is an essential glycosyltransferase, making the identification of alternative therapeutic targets crucial.

Purpose of the Study:

  • To elucidate the mechanistic underpinnings of the combined lethality induced by OGT and CDK9 inhibition.
  • To explore the distinct and overlapping roles of OGT and CDK9 in prostate cancer cell biology.

Main Methods:

  • Utilized a multiomics approach, including transcriptomics, metabolomics, and proteomics.
  • Employed weighted gene correlation network analysis (WGCNA) for systems biology insights.
  • Conducted metabolite profiling and cell-based supplementation assays.

Main Results:

  • CDK9 inhibition primarily impacted transcription, while OGT depletion significantly remodeled the metabolome.
  • CDK9 inhibition disrupted mitochondrial activity, and OGT activity was vital for maintaining mitochondrial respiration under CDK9 inhibition.
  • Pantothenic acid (vitamin B5) was identified as a key metabolite induced by OGT inhibition and combined OGT/CDK9 inhibition.

Conclusions:

  • High OGT activity is essential for maintaining mitochondrial function when CDK9 is inhibited.
  • Supplementation with vitamin B5 alongside CDK9 inhibition effectively replicates the cytotoxic effects of simultaneously targeting OGT and CDK9 in prostate cancer cells.
  • This suggests a potential therapeutic avenue involving vitamin B5 and CDK9 inhibitors for prostate cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.6K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
Global Regulatory Systems01:28

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
70